SHERRY DULLING: Open Payments
NPI 1043691884 · OLNEY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$967 in 46 payments from 18 companies in 2025. Trend: 2023 $928 · 2024 $885 · 2025 $967
Food & beverage: $967
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 9 | $185 |
| Astellas Pharma US Inc | 4 | $123 |
| Corium, LLC | 5 | $84 |
| AstraZeneca Pharmaceuticals LP | 3 | $84 |
| Merck Sharp & Dohme LLC | 4 | $71 |
| ABBVIE INC. | 3 | $66 |
| Novo Nordisk Inc | 3 | $64 |
| Axsome Therapeutics, Inc. | 2 | $40 |
| Lilly USA, LLC | 2 | $39 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $38 |
Products named: NURTEC ODT, Veozah, Azstarys, AIRSUPRA, Ozempic, M-M-R II, TRUMENBA, Auvelity.
Industry payments across MD — which companies pay providers there.
